The action establishes belzutifan as the only approved oral therapy for PPGL. The approval stipulates use in adults and ...

FDA grants accelerated approval to AbbVie's Emrelis for c-Met overexpressing NSCLC; siRNA partnership with ADARx includes ...

The U.S. Food and Drug Administration said on Wednesday it has approved the expanded use of Merck's cancer drug to treat two ...

The FDA has accepted BioCryst’s new drug application for Orladeyo in pediatric patients and set a target action date of ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, ...